Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 2,138 $ 821
Prepaid and other current assets 723 590
Total current assets 2,861 1,411
Property and equipment, net 2,528 1,409
Intangible assets, net 1,744 1,598
Right of use asset 1,709 1,842
Goodwill 652
Deferred debt issuance costs 8,261 150
Other assets 213 180
TOTAL ASSETS 17,968 6,590
Current liabilities:    
Accounts payable 1,146 865
Accrued expenses 230 621
Lease liability - current portion 598 574
Warrant liability 2,332 972
Notes payable at fair value 3,191 1,654
Notes payable 1,519 8
Total current liabilities 9,016 4,694
Lease liability - non-current portion 1,208 1,366
Total liabilities 10,224 6,060
Commitments and Contingencies (Note 14)
STOCKHOLDERS’ EQUITY:    
Preferred stock, par value $0.0001; 50,000,000 shares authorized, no shares outstanding
Series A preferred stock, par value $0.0001; 300 shares authorized, 251 shares outstanding as of March 31, 2023 and December 31, 2022; liquidation preference $255 and $251 as of March 31, 2023 and December 31, 2022, respectively
Series B preferred stock, par value $0.0001; 1,500 shares authorized, 1,443 shares outstanding as of March 31, 2023 and December 31, 2022; liquidation preference $1,464 and $1,143 as of March 31, 2023 and December 31, 2022, respectively
Series C preferred stock, par value $0.0001; 600,000 shares authorized, 500,756 shares outstanding as of March 31, 2023 and December 31, 2022; liquidation preference $501 as of March 31, 2023 and December 31, 2022, respectively
Series D preferred stock, par value $0.0001; 7,000 shares authorized, 1,058 shares issued and outstanding as of March 31, 2023 and December 31, 2022; liquidation preference $1,145 and $1,113 as of March 31, 2023 and December 31, 2022, respectively
Series E preferred stock, par value $0.0001; 77,000 shares authorized, 5,000 shares outstanding as of March 31, 2023 and no shares outstanding as of December 31, 2022
Common stock, par value $0.0001; 800,000,000 shares authorized; 43,686,523 and 20,243,509 shares outstanding as of March 31, 2023 and December 31, 2022, respectively 4 2
Additional paid-in capital 98,051 88,533
Accumulated deficit (90,311) (88,005)
Total stockholders’ equity 7,744 530
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 17,968 $ 6,590